Status:

RECRUITING

Registry for Longitudinal Mortality and Therapy in Patients With Heart Failure

Lead Sponsor:

Shanghai 10th People's Hospital

Collaborating Sponsors:

First Affiliated Hospital, Sun Yat-Sen University

Nanfang Hospital, Southern Medical University

Conditions:

Heart Failure

Eligibility:

All Genders

18-90 years

Brief Summary

The purpose of this registry is to compile a large clinical database on the medical management of patients hospitalized with acute heart failure, using information collected from hospitals across Chin...

Detailed Description

Registry for Longitudinal mortality and therapy in patients with Heart Failure is a large, multicenter, prospective, open-label registry of the management of patients treated in the hospital for acute...

Eligibility Criteria

Inclusion

  • \- 1. 18 years and older. 2. Meet the diagnostic criteria of China 2018 or JACC/AHA 2017 or ESC 2016 heart failure guidelines.
  • 3\. Agree to be tested and sign an informed consent certificate.

Exclusion

  • 1\. Age\<18 years old. 2. Patients who refused to participate. 3. Patients may have a life expectancy of less than 1 years due to non- heart failure clinical conditions.

Key Trial Info

Start Date :

January 1 2018

Trial Type :

OBSERVATIONAL

Allocation :

ESTIMATED

End Date :

December 31 2027

Estimated Enrollment :

10500 Patients enrolled

Trial Details

Trial ID

NCT04062500

Start Date

January 1 2018

End Date

December 31 2027

Last Update

August 17 2020

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Shanghai Tenth People's Hospital, Tongji University

Shanghai, Shanghai Municipality, China, 200072